ACE-Inhibitors and ARBs during COVID-19 Today’s pearl is about the use of ACE-Is and ARBs in patients with COVID-19 Should they be continued? Continue reading “ACE-Inhibitors and ARBs during COVID-19”
NSAIDs in COVID-19 Today’s pearl provides some insight and updates regarding the use of NSAIDs in patients infected with COVID-19. What should be used for fever? Continue reading “NSAIDs in COVID-19”
Ceftriaxone and Lactated Ringer Compatibility Today’s pearl addresses the safety of ceftriaxone administration in a patient also ordered for lactated ringers. Will this precipitate any problems? Continue reading “Ceftriaxone and Lactated Ringer Compatibility”
Extracorporeal Treatment for Metformin Poisoning Today’s pearl highlights an excellent resource for managing poisoned patients. Is metformin dialyzable? Continue reading “Extracorporeal Treatment for Metformin Poisoning”
IV Ondansetron in the First Trimester of Pregnancy Today’s pearl is an update on the use of ondansetron in pregnant patients. What to do when first line agents aren’t effective? Continue reading “IV Ondansetron in the First Trimester of Pregnancy”
Management of Bleeding Complications after IV Alteplase Today’s pearl describes potential treatment options for patients that develop an intracranial hemorrhage following the administration of IV alteplase (tPA). A difficult situation with no great options. Continue reading “Management of Bleeding Complications after IV Alteplase”
Onset of IM Medications for Severe Agitation Today’s pearl focuses on how fast we should expect intramuscular (IM) medications to start working in a patient with severe agitation. When soon is not soon enough. Continue reading “Onset of IM Medications for Severe Agitation”
